Your browser doesn't support javascript.
loading
Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study.
Uemura, Hiroji; Kobayashi, Kazuki; Yokomizo, Akira; Hinotsu, Shiro; Horie, Shigeo; Kakehi, Yoshiyuki; Nonomura, Norio; Ogawa, Osamu; Oya, Mototsugu; Suzuki, Kazuhiro; Saito, Atsushi; Asakawa, Keiko; Uno, Satoshi; Naito, Seiji.
Afiliación
  • Uemura H; Department of Urology and Renal Transplantation, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan. hu0428@yokohama-cu.ac.jp.
  • Kobayashi K; Department of Urology, Yokosuka Kyosai Hospital, Yonegahamadori, Yokosuka, Kanagawa, 238-8558, Japan.
  • Yokomizo A; Department of Urology, Harasanshin Hospital, 1-8 Taihakumachi, Hakata-ku, Fukuoka, 812-0033, Japan.
  • Hinotsu S; Department of Biostatistics and Data Management, Sapporo Medical University, 17 Chome Minami 1 Jonishi, Chuo Ward, Sapporo, Hokkaido, 060-8556, Japan.
  • Horie S; Department of Urology, Juntendo University, 2 Chome-1-1 Hongo, Bunkyo City, Tokyo, 113-8421, Japan.
  • Kakehi Y; Department of Medicine, Kagawa University, 1-1 Saiwaicho, Takamatsu, Kagawa, 760-0016, Japan.
  • Nonomura N; Department of Urology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, 565-0871, Japan.
  • Ogawa O; Department of Urology, Kyoto University, Yoshidahonmachi, Sakyo Ward, Kyoto, 606-8501, Japan.
  • Oya M; Department of Urology, Keio University, 2 Chome-15-45 Mita, Minato City, Tokyo, 108-8345, Japan.
  • Suzuki K; Department of Urology, Gunma University, Aramakimachi, Maebashi, Gunma, 371-8510, Japan.
  • Saito A; Medical Affairs Japan, Astellas Pharma Inc., 2-5-1 Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8411, Japan.
  • Asakawa K; Medical Affairs Japan, Astellas Pharma Inc., 2-5-1 Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8411, Japan.
  • Uno S; Data Science, Development, Astellas Pharma Inc., 2-5-1 Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8411, Japan.
  • Naito S; Department of Urology, Harasanshin Hospital, 1-8 Taihakumachi, Hakata-ku, Fukuoka, 812-0033, Japan.
Int J Clin Oncol ; 27(10): 1632-1643, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35948732
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Flutamida Límite: Humans / Male Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Flutamida Límite: Humans / Male Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Japón